Transcriptional control of the endogenous MYC protooncogene by antisense RNA.
AUTOR(ES)
Yokoyama, K
RESUMO
A plasmid carrying antisense human MYC DNA and the gene encoding Escherichia coli xanthine/guanine phosphoribosyltransferase (Ecogpt) was introduced into human promyelocytic leukemia cell line HL-60 by protoplast fusion. High-level expression of antisense MYC RNA was obtained by selecting cells resistant to progressively higher levels of mycophenolic acid over a period of greater than 6 months. The constitutive production of MYC protein in clones producing high levels of antisense MYC RNA was reduced by 70% compared to parental HL-60 cells. Inhibition of MYC expression was observed not only at the translational but also at the transcriptional level, implying that antisense RNA can regulate transcription of the MYC gene. The Pst I-Pvu II fragment (920 base pairs) of the MYC leader sequence is the primary transcriptional target of the antisense RNA. The suppression of endogenous MYC gene expression by antisense RNA decreases cell proliferation and triggers monocytic differentiation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=299296Documentos Relacionados
- Transcriptional analysis of rolling circle replicating plasmid pVT736-1: evidence for replication control by antisense RNA.
- N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts.
- Inhibition of retroviral replication by anti-sense RNA.
- Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.
- Inhibition of Rous sarcoma virus replication by antisense RNA.
